Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 Akedo Akedo +48.58%
#3 DOVU DOVU +47.59%
#4 Velvet Velvet +38.22%
#5 Black Phoenix Black Phoenix +34.27%
#6 Cross Cross +19.42%
#7 DoubleZero DoubleZero +17.37%
#8 Cap Cap +16.79%
#9 Tutorial Tutorial +15.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.89%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc.

ACOR
Classement en actions #39254
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering,... Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.
Prix de l'action
$0.879
Dernière synchronisation: 2024-05-07
Capitalisation boursière
$582.38K
Changement (1 jour)
9.88%
Changement (1 an)
0.00%
Pays
US
Échange Acorda Therapeutics, Inc. (ACOR)

Catégorie

Healthcare
Le prix ACOR avec la capitalisation boursière de B
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
ACOR
$0.879
Capitalisation boursière de Acorda Therapeutics, Inc.(ACOR)
Capitalisation boursière: $582.38K
En August 2026, Acorda Therapeutics, Inc. a une capitalisation boursière de $582.38K. Cela fait de Acorda Therapeutics, Inc. la 39254th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Acorda Therapeutics, Inc. du 2006 au 2026
ACOR par rapport au top 5 des plus populaires stocks
Prix pour ACOR L’actif B La capitalisation boursière de B Résultats
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
$8,255,283 $582.38K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +939,167,481.32%
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
$6,742,240 $582.38K
Apple Inc. Apple Inc.
AAPL
$4.467T +767,035,183.02%
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
$6,300,485 $582.38K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +716,778,630.92%
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
$5,584,601 $582.38K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +635,335,608.15%
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.
$4,308,117 $582.38K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +490,115,562.08%